Microbiology, immunology research and anti epidemic products production unit
synonymInstitute of Biology(Community of Chengdu Institute of Biological Products) generally refers to Beijing Institute of Biological Products
Beijing Institute of Biological ProductsmicrobiologyUnits engaged in immunology research and production of epidemic prevention products, with 1473 employeesScientific and technical personnel612, accounting for 42% of the total number of employees.Among them, there are 88 senior technicians and 170 intermediate technicians.
The institute is not only a unit that develops important research projects and successfully develops and popularizes important epidemic prevention products, but also an early research institute in ChinaantibioticsUnits of.
It is the first specialized agency for national health and epidemic prevention and serum vaccine research and production in China's history.In the following three decades, Beijing has moved several times and gone through hardships to develop and produce the earliestVaccinia、cholera、Typhoid fever、hydrophobia vaccineandDiphtheria antitoxin15 kinds of products;The first strain isolated in ChinapenicillinThe strain has achieved the breakthrough of zero biological products in China, continued and developed the cause of biological products in China, trained and trained professionals, and laid the foundation for the development of biological products in China.
New China was foundedLater, Beijing Institute and the Republic developed together and became more prosperous.Scientific and technological achievementstriumphant news,Asset sizeThe variety benefit is rising with continuous expansion.Tang FeifanEt alChlamydia trachomatis, access to internationaltrachomaIssued by the organizationGold medal, is an important discovery in the worldpathogenThe first Chinese to win this honor, and the only Chinese to win this honor so far;Zhao BaoSuccessful organizational research and developmentChicken embryocell cultureInstead of animal inoculation preparationVaccinia vaccine, for controlsmallpoxEven the eradication of smallpox has made outstanding contributions;freezingDrying technology、VirusesSexual vaccinecell culture technique、Apheresis PlasmaTechnology, biochemical technology for biological product verification, and blood sourcehepatitis B vaccine、Rubella vaccine, inactivated JE vaccine and other vaccines were first produced in Beijing.At the same time, Beijing Institute andInternational Health OrganizationThe contact and cooperation with relevant research institutes in various countries are increasingly strengthened. The English abbreviation of Beijing Institute is "NVSI" (National Vaccine and Service Institute), which enjoys a high reputation in the world.In the past 50 years, Beijing Institute, together with its brother Institute of Biological ProductsHygiene and epidemic preventionThe colleagues of the system work together to prevent diseasesDisinfestationWe have made great contributions to protecting people's lives and health.
Since 1998, Beijing Institute has entered a newDevelopment stage, the first listed company in China's biological products industry——Beijing Tiantan Biological Products Co., Ltd(Tiantan creature) was born.Beijing Stock Exchange reorganized high-quality assets and established Tiantan Biology by raising funds. Shanghai Securities and Exchange Commission on June 16, 1998Listing of sharesBeijing Stock Exchange held 75% of the shares during the issuance, and after several additional issuance, the holding shares of Beijing Stock Exchange were changed to 56.27%.Tiantan Biology has insisted on inheritance, innovation and development for more than ten years since it was listedOperation modeThe company has made steady development and achieved remarkable achievements.Beijing Institute has made great efforts to adapt to the new situation and gradually shifted the focus of its work to the track of focusing on scientific research.During this period, Beijing moved forward with firm exploration and worked hard in the pain of change.Scientific research work has never been mentioned to a higher position and height. Increase scientific research investment, improve scientific research conditionsManagement mechanismGradually identicalmarket economyIn line with the practice, the training and introduction of scientific research talents and the progress of research projects have become the top priorities of the whole institute.In the past ten years, VERO cell inactivated JE vaccineLeprosyDuplexMMR vaccine And injected new vitality into the development of Tiantan biology.
Since 1983, Beijing Institute has started to recruitBasic MedicineMaster, includingimmunologyIn the past 20 years, nearly 200 graduate students have been trained in two professional research directions, namely, pathogen biology and pathogen biology. Going to work has become the technical backbone of the industry.
Chinese Medical AssociationThe national first-class magazine "Chinese Journal of Microbiology and Immunology" sponsored by Beijing Institute and supported by Beijing Institute has won the National Excellent Journal Award for many times.
In order to better meet the rapid development and challenges of international biotechnology and promote ChinaBiological industryVigorously developed in the National Development and Reform Commission andBeijingWith the support of Beijing Municipal People's Government and the direct participation of the group company, Beijing Institute seized the opportunity to jointly set up the“National Engineering Research Center for New Vaccines”(Vaccine Center). The base construction of the Vaccine Center has been capped in Yizhuang Development Zone by the end of 2009. The first phase investment is more than 200 million yuan. Five pilot production lines, integrated laboratories and related facilities will be built in line with international standardssupporting facilitiesComprehensive scientific research building,Total building areaMore than 20000 square meters, mainly engaged in research and developmentIndependent intellectual property rightsOfNew vaccines。Focus on establishmentGene recombinationTechnologyMammalian cellLarge scale cultivation technologyCombined vaccine、Conjugate vaccineTechnologyDNAandPolypeptide synthesisTechnologyHumanizationMonoclonal antibodyThe key technology platform for research and development of biological products such as technology is expected to be delivered by the end of 2010.
Beijing Institute and Vaccine Center have nearly 30 research projects in progress, and have a team ofHigh quality talentsranks.Academician Zhao Jia and ShanghaiFudan UniversityWen YumeiAcademicians cooperate for treatmentChronic hepatitis BCountry ofA class of new drugs"Yike" has successfully completed Phase I and Phase IIclinical research , Phase III clinical study is in progress;EV71 vaccine research and other national priorities supported by the Ministry of Science and Technology and led by the Vaccine CenterR&D projectsWe have also made phased progress.Beijing Institute and Vaccine Center have won 25 national support projects independently or jointly with other units, and have received nearly 100 million yuan of financial support.Beijing Institute and Vaccine Center are gradually forming multidisciplinary, multi project, independent R&D andCooperative R&DCombined with medium and long-term projectsResearch and developmentSystem.A more scientific, modern and industrialized biotechnology platform is being formed withadvanced techniqueAnd the scientific research force with vigorous fighting spirit is ready to be launched.
research findings
Announce
edit
lateTang FeifanThe professor first successfully isolated chlamydia trachomatis in the world and won the gold medal of "International Trachoma Organization";The first blood source successfully developed in Chinahepatitis B vaccineWon the first prize of National Science and Technology Progress Award;In addition, more than 60 scientific research achievements have won various awards from the state, the Ministry of Health and other departments.With the development of modern biotechnology, the Institute will give full play to the advantages of traditional biotechnologygenetic engineering、cell engineering、molecular biologyAnd other fields to achieve key development and build ChinaModern biotechnologyAn important development base of products.
Ministry of Health 291-1.jpg (10723 bytes)world health organizationKeep in close contact.Some famous international scholars and officials of the World Health Organization have visited the place for many times, which has reached 600 person times since 1978;The Institutescientific and technical personnel200 experts were successively sent abroad for further study, investigation or to attend international conferences.Chen Zhengren、Zhang Yihao, Su Wannian and other experts have successively served as globalExpanded immunization programmepanel of consultantsMembers.
On March 3, 2022, Beijing Institute of Biological ProductsWuhan Institute of Bio Products Determined with Hong Kong research instituteClinical protocolAnd relevant details, on March 26 and 30, respectively, Chinese drugs and food were obtainedtestThe verification qualification report of the research institute was submitted to theHong Kong Department of HealthThe clinical application materials were submitted, and the ethical approval was obtained on April 12, and the clinical research approval was obtained on April 13, making it the first Omicron strain approved for clinical use in the worldLive vaccine.[7]
According to "Chinese Biology"WeChat official accountNews: On May 9, 2022, the sequential clinical trial of the Aomikerong inactivated coronavirus vaccine of Sinopharm Biotech Beijing Institute of Biological ProductsHunanProvincial launch.[8]
In May 2023, Sinopharm China Biotech Beijing Institute of Biological Products ACYW135 meningococcal polysaccharide vaccine was officially approvedCity.[9]
The institute produces various epidemic prevention productsBlood productsAnd diagnostic suppliesInfectious DiseasesAnd made important contributions to improving people's health and prolonging people's life span.
The office is located in three rooms in Chaoyang, with a beautiful environment and a hundred miles to the southChang'an StreetJianguo Road, northChaoyang RoadIt has direct access to the city center, convenient transportation and good communication conditions.
